Say Hello!
Don’t be shy.

   

PRESS

COVID RESPONSE

22 MARCH 2021

Scotbio secures funding in fight against future pandemics

16 DECEMBER 2020

Colour changing tech will remind users when to change face masks

02 DECEMBER 2020

ILC Therapeutics announces first international investment

11 NOVEMBER 2020

Pharm2Farm develops antiviral coating for face masks

03 NOVEMBER 2020

ILC Therapeutics announces ‘significant’ Covid-19 drug breakthrough

21 JULY 2020

PhysioWizard tackles back pain as remote working takes its toll

26 JUNE 2020

Phenotypeca win IUK grant for the ‘rapid response to covid-19’ competition

23 JUNE 2020

ILC Therapeutics partners with University of ST Andrews on COVID-19 drug

From BioCity

15 APRIL 2021

BioCity launches digital ‘Lab_13’ with Nottingham schools to inspire the next generation of scientists

01 JULY 2020

BioCity,  Innovate UK and NIHResearch announce partnership to support early-stage life science ventures

03 NOVEMBER 2020

MediCity Glasgow celebrates £26m success

01 JULY 2020

BioCity signs Time To Change Employer Pledge

11 OCTOBER 2019

BioCity hosts Ada Lovelace day to inspire the next generation of female stem scientists

BioCity invests in tech start-up INCUS Performance.

02 MAY 2019

BioCity invests in tech start-up Incus Performance.

24 APRIL 2019

BioCity invests in carbon recycling start-up, Deep Branch Biotechnology

21 JANUARY 2019

BioCity receives investment from BGF and BSI

OPINIONS

CROs have become the backbone of pharma

23 MARCH 2021

The epicentre of the drug industry: how CROs’ breadth, talent, diversity and expertise supported unprecedented sector growth to become the backbone of biopharma

10 MARCH 2021

Two years later: we catch up with Alex Birks, CEO of Med-Tech start-up Suji BFR

08 MARCH 2021

Choosing to Challenge Access to Healthcare: International Women’s Day Special Feature with Anna Maxwell

Biotech spin-out case study - Kinomica

26 JANUARY 2021

BioTech spinout case study: how specialist early-stage investment support accelerated Kinomica from seed to oversubscribed £3.9m series A

For press

BOILER PLATE

Home to more than 200 companies, BioCity is a pioneering life science incubator and business collective.

 

Not the typical business incubator, BioCity takes a holistic approach to business support. Offering entrepreneur coaching, investment, flexible lab and office space and PAYG services within a UK-wide business collective.

 

Founded in 2002 by the University of Nottingham and Nottingham Trent University, BioCity originated in a former BASF Pharma research facility in Nottingham city centre.

 

In 2012 BioCity acquired the MSD research facility in Newhouse near Glasgow to create Glasgow, BioCity. This was closely followed by a second site in Nottingham, MediCity, which is located on the Boots campus and is a collaboration with Walgreens Boots Alliance. In 2016 the Newhouse site was further expanded to create Glasgow, MediCity. BioCity also operates at Alderley Park, Cheshire, Aberdeen and Newcastle.

 

The company has made 29 investments in early stage companies and has delivered a healthy growth in portfolio valuation. Funds are deployed from its own cash reserves and from a joint venture vehicle with AstraZeneca which BioCity manages.

 

In 2017, BioCity was identified as one of Europe’s fastest growing companies in the Financial Times’ FT 1000 report. The BioCity model of ‘support from inception to incorporation’ initially challenged the industry standard but quickly became the industry leader due to the unprecedented survival rates of BioCity based businesses.

ABOUT BIOCITY.

BioCity is a pioneering life science incubator and business collective. Where ideas become reality, investment flows and businesses succeed.

 

 

BACK STORY.

BioCity was founded in 2002 when the concept of a business incubator offering 360° support within a self-contained location was unheard of. But a small team of dedicated people fought hard to turn that idea into reality. A reality now replicated throughout the UK.

Never limited to the standard business ‘incubator’ model, BioCity has grown alongside the businesses who call us home.

Our community has become a UK-wide business collective. From our locations we now provide entrepreneur coaching and investment alongside rentable lab and office space and PAYG services.

But we’re not finished yet. We work tirelessly for the pioneers who call us “home”, “coach” and “investor”, helping ideas out of the lab and into the world.

 

Even more than this, to our companies, we are a cheerleader, a critical friend & a collaborator.

 

 

THE BIOCITY BUSINESS COLLECTIVE

Entrepreneurs, investors, experts, academics, industries and associations come together at BioCity. Creating a UK-wide business collective.

We surround businesses with people who share a common goal with us and with each other – to help science entrepreneurs tackle global challenges. Individuals with diverse expertise, experience and resources who can open the doors, make the introductions and identify the opportunities; that help businesses grow.

Allowing even the smallest of ventures to be part of, and do something, big.

 

Because there’s more to life (sciences) than labs, BioCity takes a holistic approach.

 

ENTREPRENEUR COACHING

Not just for start-ups and spin-offs, we coach entrepreneurialism at every stage from idea to exit. Advocates of the Lean Start-Up method, we help businesses get off the ground and continue to grow, entrepreneurially.

 

INVESTMENT

Our panel of investment experts is adept at spotting the ‘ones to watch’, investing in promising entrepreneurs and early stage ventures with real potential.

Seed capital
Convertible loans for very early-stage ventures to help get them off the ground.

Co-investment
We identify opportunities and invite High Net Worth Individuals and sophisticated investors to co-invest in growing businesses, alongside us.

 

EXPERT NETWORK

Part of the BioCity Collective, the Expert Network are altruistic individuals our entrepreneurs can call upon for help.

They are leaders of industry, working at the highest levels in the areas of commercial science (regulatory, safety and toxicology, finance, legal, acquisition etc.) that life science entrepreneurs will tackle at some point.

 

LAB & OFFICE SPACES

Easy-in easy-out leases allow businesses to scale-up and down for new projects and new people; without the risk.

To support the science: uninterruptible power supplies, access card security systems, air handling systems and cryostorage. Class1 and class2 labs, GCP and GMP suites alongside office and co-working spaces.

To support the people: coffee houses, yoga classes, work perks and socials.

 

PAYG SERVICES

To lessen operational costs and capital expenditure, we provide services, resources and equipment on a pay-as-you-go basis.

  • Laboratory services
  • Equipment rental
  • Business services
  • Engineering
  • Meeting rooms & event spaces

BRAND ASSETS